Gottlieb to delay issuing layoff notices and reassures FDA staff that Congress will reauthorize user fees
In an email to agency staff earlier this week, FDA commissioner Scott Gottlieb said he will delay issuing layoff notices until after September 30th — when the agency’s current user fee agreements expire. Previously, the FDA indicated it could issue layoff notices to thousands of staffers funded by user fees should Congress not act by August 1st.
In the email, Gottlieb says he’s optimistic the Senate will take up the matter soon and the agency can “reasonably expect” reauthorization to occur before the September 30th deadline.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
